Cyanocobalamin Injection

Overview of Cyanocobalamin Injection

Dosage Strength

2,000 mcg/mL 5 mL Vial
2,000 mcg/mL 30 mL Vial

General Information

A vitamin from the B-complex family known as cobalamins, cyanocobalamin is one of them (corrinoids). It is a synthetic or artificial form of vitamin B12 that is sold both on the market and by prescription. There are various more chemical types of cobalamins, such as hydroxocobalamin, methylcobalamin, and adenosylcobalamin. 12 The most prevalent type of cobalamin found in dietary supplements and meals with added nutrients is cyanocobalamin. It is more stable than other forms of vitamin B12 because it has a cyano (cyanide) group in its structure, which prevents the molecule from degrading. However, because hydroxycobalamin is the form of vitamin B12 that is the most physiologically active, it is preferred over cyanocobalamin for the treatment of vitamin B12 deficiency.1234

Foods do not normally contain cyanocobalamin because cyanide, which is not in the vitamin’s natural form, is present. The uncommon mineral cobalt (4.34 percent) is a component of cyanocobalamin’s chemical structure and is responsible for binding the cyano group to a corrin ring in the middle of the compound. 5 Bacterial fermentation is used in the commercial production of the vitamin. It is more air-stable and easier to crystallize than other forms of vitamin B12. 3 Orthorhombic needles, red crystals, or a dark red, amorphous or crystalline powder are the most common forms of cyanocobalamin. The substance is extremely hygroscopic in its anhydrous state. If exposed to air, it may absorb up to 12% of water. Cyanocobalamin is insoluble in chloroform, acetone, and ether but only sporadically soluble in alcohol and water (1 in 80 of water). This vitamin’s coenzymes are very light-sensitive. 6

There are numerous dosing forms for cyanocobalamin, including tablets, nasal spray, and injectable. The medication was first given approval by the US-FDA in 1942. 7 But in the early 1950s, the drug became widely accessible for regular usage in the management of B12 insufficiency. 8


1.Markle HV, Greenway DC. Cobalamin. Critical reviews in clinical laboratory sciences. 1996; 33: 247-356.
2.Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem. 2012; 56: 301-322.
3.Paul C, Brady DM. Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements With Potential to Mitigate B12-related Genetic Polymorphisms. Integrative Medicine: A Clinician’s Journal. 2017; 16: 42–49.
4.Vidal‐Alaball J, Butler C, Cannings‐John R, Goringe A, Hood K, McCaddon A, McDowell I, Papaioannou A. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database of Systematic Reviews. 2005: CD004655.
5.O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010; 2: 299-316.
6.Sweetman SC, editor. Martindale: the complete drug reference, 34th ed. London: Pharmaceutical press; 2014.
7.CaloMist™ Nasal Spray (cyanocobalamin, USP) label. 2007. Available from: [Accessed October 23, 2020].
8.Berry RJ. Lack of historical evidence to support folic acid exacerbation of the neuropathy caused by vitamin B12 deficiency. The American journal of clinical nutrition. 2019; 110: 554-61.
9.Alamin A, Gupta V. Vitamin B12 (Cobalamin). In: StatPearls [Internet]. 2020. StatPearls Publishing.
10.Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle—biochemistry, pathways, and regulation. Journal of inherited metabolic disease. 2019; 42: 673-685.
11.Berney M, Berney-Meyer L, Wong KW, Chen B, Chen M, Kim J, Wang J, Harris D, Parkhill J, Chan J, Wang F. Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 2015; 112: 10008-10013.
12.Vasavada A, Sanghavi D. Cyanocobalamin. In: StatPearls [Internet] 2020. StatPearls Publishing.
13.Sanz-Cuesta T, González-Escobar P, Riesgo-Fuertes R, Garrido-Elustondo S, del Cura-González I, Martín-Fernández J, Escortell-Mayor E, Rodríguez-Salvanés F, García-Solano M, González-González R, Martín-de la Sierra MÁ. Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12). BMC Public Health. 2012; 12:1-1.
14.Scott JM. Bioavailability of vitamin B12. European journal of clinical nutrition. Supplement. 1997; 51: S49-S53.
15.CYANOCOBALAMIN INJECTION, USP 1000 mcg/mL Sterile (Vitamin B12) [Label]. 2014. Available from: [Accessed October 26, 2020].
16.CYANOCOBALAMIN- cyanocobalamin injection, USP. West-Ward Pharmaceuticals Corp [Label]. 2018. Available from: [Accessed October 26, 2020].
17.Watanabe F. Vitamin B12 sources and bioavailability. Experimental biology and medicine. 2007; 232: 1266-1274.
18.Andrès E, Serraj K, Zhu J, Vermorken AJ. The pathophysiology of elevated vitamin B12 in clinical practice. QJM: An International Journal of Medicine. 2013; 106: 505-515.
19.Gherasim C, Lofgren M, Banerjee R. Navigating the B12 road: assimilation, delivery, and disorders of cobalamin. Journal of Biological Chemistry. 2013; 288: 13186-13193.
20.Nascobal® (Cyanocobalamin, USP) Nasal Spray 500 mcg/spray 0.125 mL [Label]. 2014. Available from: [Accessed October 26, 2020].
21.Caballero MR, Lukawska J, Lee TH, Dugué P. Allergy to vitamin B12: two cases of successful desensitization with cyanocobalamin. Allergy. 2007; 62: 1341-1342.
22.Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008; 112: 2214-2221.
23.Solomon LR. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood reviews. 2007; 21: 113-130.
24.Chandyo RK, Ulak M, Kvestad I, Shrestha M, Ranjitkar S, Basnet S, Hysing M, Shrestha L, Strand TA. The effects of vitamin B12 supplementation in pregnancy and postpartum on growth and neurodevelopment in early childhood: Study Protocol for a Randomized Placebo Controlled Trial. BMJ open. 2017; 7: e016434.
25.Samson RR, McClelland DB. Vitamin B12 in human colostrum and milk: quantitation of the vitamin and its binder and the uptake of bound vitamin B12 by intestinal bacteria. Acta Pædiatrica. 1980; 69: 93-99.
26.American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001; 10

Legal Disclaimer: All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice.